Filing Details
- Accession Number:
- 0000905148-24-002703
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-10 18:11:27
- Reporting Period:
- 2024-10-08
- Accepted Time:
- 2024-10-10 18:11:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1720420 | Ibex Ltd | IBEX | Services-Computer Processing & Data Preparation (7374) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1902511 | Pinebridge Gem Ii G.p., L.p. | 65 East 55Th Street New York NY 10022 | No | No | No | No | |
1974212 | John Leone | 65 East 55Th Street New York NY 10022 | No | No | No | No | |
1984821 | Pierre Mellinger | 65 East 55Th Street New York NY 10022 | No | No | No | No | |
1984823 | Kevin Clowe | 65 East 55Th Street New York NY 10022 | No | No | No | No | |
1984825 | Pinebridge Global Emerging Markets Partners Ii, L.p. | 65 East 55Th Street New York NY 10022 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Disposition | 2024-10-08 | 20,000 | $19.05 | 1,754,739 | No | 4 | S | Indirect | See Footnotes |
Common Shares | Disposition | 2024-10-09 | 15,358 | $19.26 | 1,739,381 | No | 4 | S | Indirect | See Footnotes |
Common Shares | Disposition | 2024-10-10 | 19,642 | $19.03 | 1,719,739 | No | 4 | S | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Indirect | See Footnotes |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by PineBridge Global Emerging Markets Partners II, L.P., a Cayman Islands limited partnership ("GEM II"), on June 14, 2024.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from 18.90 to $19.315, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This is a joint filing by GEM II, PineBridge GEM II G.P., L.P., a Cayman Islands limited partnership ("GEM II GP"), John Leone, Kevin Clowe and Pierre Mellinger. The reported shares are held directly by GEM II. GEM II GP is the sole director of PineBridge GEM II GP Ltd., which is the sole general partner of GEM II. Mr. Leone, Mr. Clowe and Mr. Mellinger serve on the three-member investment committee of GEM II GP, which manages the investment activities of GEM II.
- GEM II GP, Mr. Leone, Mr. Clowe and Mr. Mellinger disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission of beneficial ownership of the securities for purposes of Section 16 or any other purpose.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.17 to $19.695, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.785 to $19.43, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.